JOSEPHINE AIDELOJE: Open Payments
NPI 1790272243 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 21 payments from 9 companies in 2025. Trend: 2023 $148 · 2024 $219 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $185 |
| Janssen Pharmaceuticals, Inc | 4 | $101 |
| Alkermes, Inc. | 2 | $62 |
| Sage Therapeutics, LLC | 2 | $42 |
| Lundbeck LLC | 2 | $37 |
| ABBVIE INC. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Corium, LLC | 1 | $6 |
Products named: REXULTI, INVEGA SUSTENNA, ARISTADA, ABILIFY ASIMTUFII, ZURZUVAE, VRAYLAR, INGREZZA, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
